David Michael Frazer

Dr. David Michael Frazer


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Cell
Verified
Journal Article
Closed access
MSMajid Shayeghi
Majid Shayeghi
GLGladys O. Latunde-Dada
Gladys O. Latunde-Dada
JOJonathan S. Oakhill
Jonathan S. Oakhill
ALAbas H. Laftah
Abas H. Laftah
KTKen Takeuchi
Ken Takeuchi
AMAndrew T. McKie
Andrew T. McKie

1 February 2003 in The Lancet
Verified
Journal Article
Closed access
KBKim R Bridle
Kim R Bridle
DFDavid Michael Frazer
David Michael Frazer
SWSarah J Wilkins
Sarah J Wilkins
JDJeanette L Dixon
Jeanette L Dixon
DPDavid M Purdie
David M Purdie
GRGrant A Ramm
Grant A Ramm

1 September 2002 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
DFDavid Michael Frazer
David Michael Frazer
SWSarah J. Wilkins
Sarah J. Wilkins
EBErika M. Becker
Erika M. Becker
CVChristopher D. Vulpe
Christopher D. Vulpe
AMAndrew T. Mckie
Andrew T. Mckie
Greg AndersonGreg Anderson
Greg Anderson

17 October 2013 in BioFactors
Verified
Journal Article
Closed access
PDF file
DFDavid Michael Frazer
David Michael Frazer
Greg AndersonGreg Anderson
Greg Anderson

20 November 2009 in Hepatology
Verified
Journal Article
Open access
PDF file
DWDaniel Wallace
Daniel Wallace
LSLesa Summerville
Lesa Summerville
ECEmily M. Crampton
Emily M. Crampton
DFDavid Michael Frazer
David Michael Frazer
Greg AndersonGreg Anderson
Greg Anderson
VSV. Nathan Subramaniam
V. Nathan Subramaniam
Hepcidin is a central regulator of iron homeostasis. HFE and transferrin receptor 2 (TFR2) are mutated in adult-onset forms of hereditary hemochromatosis and regulate the expression of hepcidin in response to iron. Whether they act through the same or parallel pathways is unclear. To investigate this, we generated a mouse model with deletion of both Hfe and Tfr2 genes by crossing Hfe and Tfr2 null mice on a genetically identical background. Tissue and serum from wildtype, single-, and double-null mice were analyzed. Serum transferrin saturation and hepatic iron concentrations were determined. The expression of iron-related messenger RNA (mRNA) transcripts was analyzed by real-time polymerase chain reaction (PCR). Levels of the iron-related proteins Tfr1, Tfr2, ferritin, and prohepcidin, and the phosphorylation status of the cell signaling proteins extracellular signal-regulated kinase 1/2 (Erk1/2) and Smad1/5/8, were analyzed by immunoblotting. Double-null mice had more severe iron loading than mice lacking either Hfe or Tfr2; Tfr2 null mice had a greater iron burden than Hfe-null mice. Hepcidin expression relative to iron stores was reduced in the Hfe-null mice, with significantly lower values in the Tfr2-null mice. In the absence of both Hfe and Tfr2, hepcidin expression was reduced even further. A significant decrease in phospho-Erk1/2 in the livers of null mice and a reduction in phospho-Smad1/5/8 suggest that both the mitogen-activated protein kinase (MAPK) and bone morphogenetic protein / mothers against decapentaplegic homolog (BMP/SMAD) signaling pathways may be involved in Hfe- and Tfr2-mediated regulation of hepcidin. Conclusion: These studies demonstrate that iron overload due to deletion of Tfr2 is more severe than that due to Hfe, and that loss of both molecules results in pronounced iron overload. Analysis of Hfe/Tfr2 double-null mice suggests that Hfe and Tfr2 regulate hepcidin through parallel pathways involving Erk1/2 and Smad1/5/8. (HEPATOLOGY 2009.)

1 May 2003 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
DFDavid Michael Frazer
David Michael Frazer
Greg AndersonGreg Anderson
Greg Anderson